Patent · US Active

Transdermal therapeutic system for administering lipophilic and/or sparingly skin-permeable active substances

US9486417B2 · kind B2 · utility

0Cited by

6References

24Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Andreas Koch · Heiligenhaus, DE
Christoph Schmitz · Euskirchen, DE
Rolf Pracht · Höhr-Grenzhausen, DE
Mohammad Sameti · Bonn, DE

Key dates

Filing date	Aug 22, 2012
Grant date	Nov 8, 2016
Priority date	—
Expiry date	Mar 17, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A transdermal therapeutic system for administering lipophilic, poorly water-soluble and/or sparingly skin-permeable pharmaceutical active substances. The active substance is present in a multi-component enhancer system consisting of 4 components and each component of the multi-component enhancer system is selected from a different one of the substance groups: a) terpenes, b) cyclic glucitol ethers, c) medium-chain triglycerides of capric and caprylic acid and/or of linoleic acid; and d) longer-chain alcohols having a chain length of 8 or more carbon atoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.